174 related articles for article (PubMed ID: 24606425)
1. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells.
You ZM; Zhao L; Xia J; Wei Q; Liu YM; Liu XY; Chen DL; Li J
Asian Pac J Cancer Prev; 2014; 15(3):1099-104. PubMed ID: 24606425
[TBL] [Abstract][Full Text] [Related]
2. Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.
Li Y; Wei Z; Dong B; Lian Z; Xu Y
Int J Mol Med; 2016 Apr; 37(4):998-1004. PubMed ID: 26936801
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
4. AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
Oncotarget; 2015 Sep; 6(28):26373-87. PubMed ID: 26308071
[TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
[TBL] [Abstract][Full Text] [Related]
6. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Funasaka T; Yanagawa T; Hogan V; Raz A
FASEB J; 2005 Sep; 19(11):1422-30. PubMed ID: 16126909
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Tsutsumi S; Hogan V; Nabi IR; Raz A
Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
Funasaka T; Hu H; Hogan V; Raz A
J Biol Chem; 2007 Dec; 282(50):36362-9. PubMed ID: 17925402
[TBL] [Abstract][Full Text] [Related]
9. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
[TBL] [Abstract][Full Text] [Related]
10. PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.
Shih WL; Liao MH; Lin PY; Chang CI; Cheng HL; Yu FL; Lee JW
Cancer Lett; 2010 Apr; 290(2):223-37. PubMed ID: 19819066
[TBL] [Abstract][Full Text] [Related]
11. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Yanagawa T; Funasaka T; Tsutsumi S; Raz T; Tanaka N; Raz A
J Biol Chem; 2005 Mar; 280(11):10419-26. PubMed ID: 15637053
[TBL] [Abstract][Full Text] [Related]
13. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
14. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
Niinaka Y; Harada K; Fujimuro M; Oda M; Haga A; Hosoki M; Uzawa N; Arai N; Yamaguchi S; Yamashiro M; Raz A
Cancer Res; 2010 Nov; 70(22):9483-93. PubMed ID: 20978190
[TBL] [Abstract][Full Text] [Related]
15. Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Funasaka T; Hogan V; Raz A
Cancer Res; 2009 Jul; 69(13):5349-56. PubMed ID: 19531650
[TBL] [Abstract][Full Text] [Related]
16. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL
Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 Inhibits Cell Proliferation and Induces Markers of Cell Senescence in CD34+CD38- Leukemia Stem Cells Derived from KG1α Acute Myeloid Leukemia Cells by Activating the Sirtuin 1 (SIRT1)/Tuberous Sclerosis Complex 2 (TSC2) Signaling Pathway.
Tang YL; Zhang CG; Liu H; Zhou Y; Wang YP; Li Y; Han YJ; Wang CL
Med Sci Monit; 2020 Feb; 26():e918207. PubMed ID: 32037392
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Tsutsumi S; Yanagawa T; Shimura T; Fukumori T; Hogan V; Kuwano H; Raz A
J Biol Chem; 2003 Aug; 278(34):32165-72. PubMed ID: 12783864
[TBL] [Abstract][Full Text] [Related]
20. Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.
Luo N; Zhao LC; Shi QQ; Feng ZQ; Chen DL; Li J
Asian Pac J Cancer Prev; 2015; 16(8):3509-15. PubMed ID: 25921170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]